---
title: "New Stock Debut | HERBS GROUP listed on the first day with a 25.07% increase in early trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/222740157.md"
description: "HERBS GROUP has officially listed, with the announcement showing a pricing of HKD 3.75 per share, issuing a total of 33.336 million shares, with each lot consisting of 800 shares. The net proceeds are expected to be approximately HKD 95.3 million. As of the time of writing, the stock has risen by 25.07%, trading at HKD 4.69, with a transaction volume of HKD 83.0369 million. Public information indicates that HERBS GROUP is a diversified supplier of health and beauty products rooted in Hong Kong for over twenty years, employing a multi-channel sales model and focusing on the development, sales, and marketing of its own branded products. Since its establishment in 1999, the group has sold a wide range of products and actively built its own brands. As of the last feasible date, it operated a total of eight proprietary brands. According to the Frost & Sullivan report, in 2023, among all international and local health supplement suppliers in Hong Kong, the company ranked fifth in retail sales of immune system health products, with a market share of approximately 4.9%; and ranked tenth in retail sales of health supplements, with a market share of approximately 3.6%. As of the last feasible date, the company had 33 self-operated stores and two brand experience centers distributed across various districts in Hong Kong, over 80 wholesale customers, and two consignment merchants"
datetime: "2024-12-19T01:25:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/222740157.md)
  - [en](https://longbridge.com/en/news/222740157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/222740157.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/222740157.md) | [繁體中文](https://longbridge.com/zh-HK/news/222740157.md)


# New Stock Debut | HERBS GROUP listed on the first day with a 25.07% increase in early trading

According to the Zhitong Finance APP, HERBS GROUP (02593) has officially listed, with an announcement showing a pricing of HKD 3.75 per share, issuing a total of 33.336 million shares, with each board lot consisting of 800 shares. The net proceeds are expected to be approximately HKD 95.3 million. As of the time of writing, the stock has risen by 25.07%, trading at HKD 4.69, with a transaction volume of HKD 83.0369 million.

Public information shows that HERBS GROUP is a diversified supplier of health and beauty products rooted in Hong Kong for over twenty years, employing a multi-channel sales model and focusing on the development, sales, and marketing of its own branded products. Since its establishment in 1999, the group has sold a wide range of products and actively built its own brands. As of the last feasible date, it operates a total of eight proprietary brands.

According to a report by Frost & Sullivan, in 2023, among all international and local health supplement suppliers in Hong Kong, the company ranked fifth in retail sales of immune system health products, with a market share of approximately 4.9%; and ranked tenth in health supplement retail sales, with a market share of approximately 3.6%. As of the last feasible date, the company has 33 self-operated stores and two brand experience centers located in various districts of Hong Kong, over 80 wholesale customers, and two consignment merchants

### Related Stocks

- [HERBS GROUP (02593.HK)](https://longbridge.com/en/quote/02593.HK.md)
- [Kingdomway (002626.CN)](https://longbridge.com/en/quote/002626.CN.md)
- [EC HEALTHCARE (02138.HK)](https://longbridge.com/en/quote/02138.HK.md)
- [LANCY (002612.CN)](https://longbridge.com/en/quote/002612.CN.md)
- [GUANGJI PHARMA (000952.CN)](https://longbridge.com/en/quote/000952.CN.md)
- [The Procter & Gamble Company (PG.US)](https://longbridge.com/en/quote/PG.US.md)
- [BYHEALTH (300146.CN)](https://longbridge.com/en/quote/300146.CN.md)
- [Fuerjia (301371.CN)](https://longbridge.com/en/quote/301371.CN.md)
- [TOPSPORTS (06110.HK)](https://longbridge.com/en/quote/06110.HK.md)
- [BEAUTYFARM MED (02373.HK)](https://longbridge.com/en/quote/02373.HK.md)
- [Shanghai Jahwa (600315.CN)](https://longbridge.com/en/quote/600315.CN.md)
- [CHOW TAI FOOK (01929.HK)](https://longbridge.com/en/quote/01929.HK.md)
- [BTN (300957.CN)](https://longbridge.com/en/quote/300957.CN.md)
- [PAB (000001.CN)](https://longbridge.com/en/quote/000001.CN.md)
- [SISRAM MED (01696.HK)](https://longbridge.com/en/quote/01696.HK.md)
- [Bloomage Biotech (688363.CN)](https://longbridge.com/en/quote/688363.CN.md)
- [HPGC (600664.CN)](https://longbridge.com/en/quote/600664.CN.md)
- [GIANT BIOGENE (02367.HK)](https://longbridge.com/en/quote/02367.HK.md)

## Related News & Research

- [Herbs Generation Swings to 2025 Loss as Margins and Sales Decline](https://longbridge.com/en/news/280317330.md)
- [Xpeng Mar deliveries rebound sequentially despite year-on-year decline](https://longbridge.com/en/news/281331957.md)
- [Several Baidu Apollo Go Robotaxis Freeze In China, Raising Concerns About AV Safety: Report](https://longbridge.com/en/news/281345987.md)
- [Nio to launch 2026 ES6, EC6, ET5, and ET5 Touring on Apr 2](https://longbridge.com/en/news/281291925.md)
- [PREVIEW-Tesla Q1 deliveries likely to dip sequentially as EV demand softens](https://longbridge.com/en/news/281342986.md)